Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 19, 2016 15:15 ET | Source: PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals Announces the Addition of Dr. Simon Wood PhD as the Company’s new Scientific Officer with plans to expand its Current Portfolio of Veterinarian Drugs and Nutraceuticals

Hancock, MD, Oct. 19, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
October 17, 2016 08:00 ET | Source: PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals is Pleased to Announce the Completion of the New Company Website

Hancock, MD, Oct. 17, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
October 13, 2016 08:00 ET | Source: PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals Expands Cell Line Study with InnoVision in Preparation for FDA/CVM Registration Submission

Hancock, MD, Oct. 13, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
October 10, 2016 08:00 ET | Source: PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals is Pleased to Showcase its New “Vitalzul™ Information Video” along with a Corporate Update

Hancock, MD, Oct. 10, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
September 28, 2016 10:30 ET | Source: PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals Explores Product Expansion with Strategic Partner(s); Successfully Presents at Two Financial Conferences in September

Hancock, MD , Sept. 28, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLFD) (the "Company"), the developer of Vitalzul™, a new generation of high potency veterinary cancer...
September 14, 2016 09:10 ET | Source: PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals Continues Execution of its Vitalzul TM Business Plan with start of Proof of Concept studies; Provides Updates

Hancock, MD, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Hancock, MD - PetLife Pharmaceuticals, Inc. (OTC QB: PTLFD) (the "Company"), a developer of Vitalzul™, a new generation of high potency veterinary...
September 07, 2016 11:00 ET | Source: PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals Announces pre-INAD (Investigational New Animal Drug) Cell Lines Study of Vitalzul™ has Begun

Hancock, MD, Sept. 07, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
September 01, 2016 09:00 ET | Source: PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals Sees Vitalzul™ as a Major Component in the Treatment of Cancer in Pets; Releases Vitalzul™ Information and Testimonial Video

Hancock, MD, Sept. 01, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
August 25, 2016 08:43 ET | Source: PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals Hires InnoVision Therapeutics in Preparation of Vitalzul™ FDA Submission

HANCOCK, Md., Aug. 25, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB:PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
August 23, 2016 14:35 ET | Source: PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals Announces Investor Analysts Research Report

Hancock, MD, Aug. 23, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right